Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Nesvategrast (OTT166) in Diabetic Retinopathy (DR)

ClinicalTrials.gov ID: NCT05409235

Public ClinicalTrials.gov record NCT05409235. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 7:41 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

OTT166-201 A Phase 2 Randomized, Double-Masked, Vehicle-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of OTT166 Ophthalmic Solution in the Treatment of Diabetic Retinopathy (DR)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of OTT166 Ophthalmic solution in participants with Diabetic Retinopathy.

Study identification

NCT ID
NCT05409235
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
OcuTerra Therapeutics, Inc.
Industry
Enrollment
225 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 29, 2022 (Actual)
Primary completion
Dec 29, 2023 (Actual)
Completion
Dec 29, 2023 (Actual)
Last update posted
Aug 9, 2024

2022 – 2023

United States locations

U.S. sites
67
U.S. states
28
U.S. cities
62
Facility City State ZIP Site status
Clinical Site 123 Peoria Arizona 85381 —
Clinical Site 150 Phoenix Arizona 85021 —
Clinical Site 111 Beverly Hills California 90211 —
Clinical Site 113 Encino California 91436 —
Clinical Site 138 Fresno California 93720 —
Clinical Site 129 Huntington Beach California 92647 —
Clinical Site 121 Pasadena California 91105 —
Clinical Site 127 Pasadena California 91107 —
Clinical Site 142 Rancho Cordova California 95670 —
Clinical Site 116 Riverside California 92505 —
Clinical Site 125 Sacramento California 95841 —
CinCor Site 171 Torrance California 90505 —
Clinical Site 160 Walnut Creek California 94598-5910 —
Clinical Site 157 Coral Springs Florida 33067 —
Clinical Site 106 Fort Lauderdale Florida 33309 —
Clinical Site 131 Jacksonville Florida 32216 —
Clinical Site 110 Miami Florida 33143 —
Clinical Site 153 St. Petersburg Florida 33711-1141 —
Clinical Site 117 Winter Haven Florida 33880 —
Clinical Site 112 ‘Aiea Hawaii 96701 —
Clinical Site 146 Oak Forest Illinois 60452 —
Clinical Site 128 Springfield Illinois 62704 —
Clinical Site 154 Indianapolis Indiana 46290-1166 —
Clinical Site 139 Lenexa Kansas 66215 —
Clinical Site 166 Louisville Kentucky 40206 —
Clinical Site 167 Metairie Louisiana 70006 —
Clinical Site 163 Baltimore Maryland 21237 —
Clinical Site 145 Baltimore Maryland 21287 —
Clinical Site 103 Hagerstown Maryland 21740 —
Clinical Site 151 Boston Massachusetts 02111 —
Clinical Site 104 Boston Massachusetts 02114 —
Clinical Site 141 Detroit Michigan 48201 —
Clinical Site 155 Southaven Mississippi 38671 —
Clinical Site 101 Reno Nevada 89502 —
Clinical Site 105 Bloomfield New Jersey 07003 —
Clinical Site 136 Cherry Hill New Jersey 08034 —
Clinical Site 114 Teaneck New Jersey 07666 —
Clinical Site 118 Albuquerque New Mexico 87109 —
Clinical Site 109 Liverpool New York 13088 —
Clinical Site 162 Rochester New York 14618 —
Clinical Site 165 Raleigh North Carolina 27587 —
Clinical Site 143 Beachwood Ohio 44122 —
Clinical Site 120 Cleveland Ohio 44122 —
Clinical Site 152 Dublin Ohio 43016 —
Clinical Site 122 Edmond Oklahoma 73013 —
Clinical Site 135 Portland Oregon 97239 —
Clinical Site 158 Springfield Oregon 97477 —
Clinical Site 115 Kingston Pennsylvania 18704 —
Clinical Site 130 Beaufort South Carolina 29902 —
Clinical Site 133 Rapid City South Dakota 57701 —
Clinical Site 168 Germantown Tennessee 38138 —
Clinical Site 164 Knoxville Tennessee 37909-2686 —
Clinical Site 169 Memphis Tennessee 38119 —
Clinical Site 119 Nashville Tennessee 37203 —
Clinical Site 161 Austin Texas 78705 —
Clinical Site 102 Bellaire Texas 77401 —
Clinical Site 108 Bellaire Texas 77401 —
Clinical Site 147 Burleson Texas 76028 —
Clinical Site 132 Fort Worth Texas 76104 —
Clinical Site 156 Houston Texas 77025 —
Clinical Site 126 McAllen Texas 78503 —
Clinical Site 140 San Antonio Texas 78240-1375 —
Clinical Site 137 San Antonio Texas 78240 —
Clinical Site 144 Texas City Texas 78240 —
Clinical Site 159 Lynchburg Virginia 24502 —
Clinical Site 149 Seattle Washington 98125 —
Clinical Site 148 Spokane Washington 98204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05409235, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2024 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05409235 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →